表紙
市場調査レポート

脳性麻痺:世界の治験レビュー

Cerebral Palsy Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 222289
出版日 ページ情報 英文 78 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
脳性麻痺:世界の治験レビュー Cerebral Palsy Global Clinical Trials Review, H1, 2014
出版日: 2014年05月26日 ページ情報: 英文 78 Pages
概要

当レポートでは、脳性麻痺に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、主な先進国・新興国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤などの情報を盛り込んで、概略以下の構成でお届けします。

目次

イントロダクション

  • 脳性麻痺
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の上位5ヶ国
    • 欧州の上位5ヶ国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国での治験件数:中枢神経系疾患治験全体における脳性麻痺の割合

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系疾患治験全体における脳性麻痺の割合

E7諸国での治験件数:フェーズ(相)別

E7諸国での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

  • 脳性麻痺治療薬の治験に参加している上位企業

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Allergan, Inc.
    • Ipsen S.A.
    • Merz Pharma GmbH & Co. KgaA
    • Medtronic, Inc.
    • Acorda Therapeutics, Inc.
    • GlaxoSmithKline plc
    • 第一三共
  • 代表的な研究機関・病院の治験の概要
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • The Sheba Medical Center
    • Shriners Hospitals for Children
    • VU University Medical Center
    • Bundang Cha Hospital
    • National Institute of Neurological Disorders and Stroke
    • Chang Gung Memorial Foundation
    • Stanford University
    • Hvidovre University Hospital
    • Shaare Zedek Medical Center

5つの代表的な治験のプロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2156CTIDB

GlobalData's clinical trial report, "Cerebral Palsy Global Clinical Trials Review, H1, 2014" provides data on the Cerebral Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Palsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cerebral Palsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Cerebral Palsy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Cerebral Palsy to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Cerebral Palsy to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Cerebral Palsy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Cerebral Palsy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Allergan, Inc.
      • Clinical Trial Overview of Allergan, Inc.
      • Ipsen S.A.
      • Clinical Trial Overview of Ipsen S.A.
      • Merz Pharma GmbH & Co. KgaA
      • Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA
      • Medtronic, Inc.
      • Clinical Trial Overview of Medtronic, Inc.
      • Acorda Therapeutics, Inc.
      • Clinical Trial Overview of Acorda Therapeutics, Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
    • Clinical Trial Overview of Top Institutes / Government
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • The Sheba Medical Center
      • Clinical Trial Overview of The Sheba Medical Center
      • Shriners Hospitals for Children
      • Clinical Trial Overview of Shriners Hospitals for Children
      • VU University Medical Center
      • Clinical Trial Overview of VU University Medical Center
      • Bundang Cha Hospital
      • Clinical Trial Overview of Bundang Cha Hospital
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • Chang Gung Memorial Foundation
      • Clinical Trial Overview of Chang Gung Memorial Foundation
      • Stanford University
      • Clinical Trial Overview of Stanford University
      • Hvidovre University Hospital
      • Clinical Trial Overview of Hvidovre University Hospital
      • Shaare Zedek Medical Center
      • Clinical Trial Overview of Shaare Zedek Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2014*
  • Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cerebral Palsy Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Cerebral Palsy Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Cerebral Palsy Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bundang Cha Hospital, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaare Zedek Medical Center, 2014*

List of Figures

  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top